Australian Biotechnology News

RNAi

News
  • +

    Argy-bargy continues at Avexa 27/08/2010 15:28:00

    Major shareholder Calzada calls for EGM in September
    Troubled HIV drug developer Avexa may be poised for yet another coup after major shareholder Caldaza this week called for an extraordinary general meeting to discuss the future of the company
  • +

    Professor Philip Hogg wins lead Eureka prize 20/08/2010 16:37:00

    Clinical research underway for new cancer drugs which prevent tumours from being able to generate new blood vessels
    Professor Philip Hogg, Director of the new Lowy Cancer Research Centre at the University of NSW, has received the prestigious 2010 Industry & Investment NSW Eureka Prize for Medical Research Translation.
  • +

    Specialised Therapeutics announces success of compassionate cancer program 18/08/2010 20:41:00

    Nanoparticle drug Abraxane shown to be effective against melanoma, pancreatic and lung cancers
    A compassionate program run by Melbourne biotech Specialised Therapeutics (STA) has helped more than 240 Australian cancer patients to benefit from a world-leading new treatment based on nanoparticles, the company said.
  • +

    Want a career in science? Good at maths? Bioinformatics needs you! 05/08/2010 17:14:00

    Demand for bioinformatics, mathematics and statistics specialists in the life sciences is increasing as data demands mushroom, says Nobel Laureate, Professor Peter Doherty.
    The staggering amounts of data being generated in genomics, epigenomics, proteomics and other ‘omics studies - not to mention systems biology, which attempts to knit the various ‘omics together - is presenting a titanic challenge for life science researchers.
  • +

    WAIMR to fund two new melanoma projects 30/07/2010 16:28:00

    Researchers hope to improve chemotherapy drugs and discover new melanoma treatments
    The Western Australian Institute for Medical Research (WAIMR) has awarded grants of $75,000 each to two of its scientists hoping to identify new treatments for melanoma as well as boost the effectiveness of chemotherapy drugs against the disease.
  • +

    Australian Life Scientist July/August edition out now 28/07/2010 15:36:00

    The Human Proteome Organisation (HPUO) 2010 World Congress and the Human Proteome Project feature in this issue, along with proteomics, synthetic biology, genetics and genomics, and next generation genome sequencing.
    The July/August edition of Australian Life Scientist is out now. The issue takes an in-depth look at the happenings at the upcoming Human Proteome Organisation (HPUO) 2010 World Congress, which will host the launch of the long awaited Human Proteome Project.
  • +

    Feature: RNAi delivers double whammy to cancer 22/07/2010 10:20:00

    Renowned cancer expert, Professor Bryan Williams, is showing how RNA-interference technology can deliver a double-whammy to tumours.
    RNA interference (RNAi) was little more than an enigmatic laboratory phenomenon just 15 years ago, but has since been fashioned into a Swiss Army knife, bristling with new blades and widgets for biological and medical research.
  • +

    Feature: How next generation sequencing could save the Tasmanian devil 15/07/2010 12:48:00

    Tasmanian-born scientist, Dr Elizabeth Murchison, is using the latest next generation sequencing technology in an effort to rid the Tasmanian devil of the lethal facial tumours.
    The devil facial tumour disease (DFTD) is a rare type of infectious cancer that threatens to rid Australia of one of its most iconic marsupials: the cute (sort of), and feisty (definitely), Tasmanian devil (Sarcophilus harrisii).
  • +

    Queensland’s best researchers honoured in QHMR Awards 10/06/2010 15:20:00

    Sunshine state shines light on breakthroughs for pain, immunology, lymphoma and post transplant disorders.
    The Queensland Health and Medical Research Awards held in Brisbane last Friday honoured a number of outstanding individuals for their work in areas including pain treatment, immunology, lymphoma and post transplant disorders.
  • +

    Opinion: The need to back young scientisits 09/06/2010 14:17:00

    Australia’s research funding culture favours experienced scientists at the expense of promoting young researchers with great potential.
    Australia’s research funding culture favours experienced scientists at the expense of promoting young researchers with great potential. Changes must be made if the future of Australian science is to be placed in safe hands.
Interviews
  • +

    Sequencing most fowl: a poultry challenge 13/06/2008 15:34:00

    Deciphering vertebrate development, sorting out the roosters from the hens and taking on bird flu – dare we say, all in one fowl swoop – that is the job of CSIRO’s Dr Mark Tizard, who has created a new microRNA catalogue for the humble chook.
    Deciphering vertebrate development, sorting out the roosters from the hens and taking on bird flu - dare we say, all in one fowl swoop - that is the job of CSIRO's Dr Mark Tizard, who has created a new microRNA catalogue for the humble chook.
  • +

    Preventing transgene escape with RNAi 13/06/2008 15:37:00

    Rightly or wrongly, concerns over GM crops contaminating their non-GM kin have led to a stalemate in progress towards acceptance of GM crops and foods. We look at a new approach using gene silencing and gene imprinting.
    Rightly or wrongly, concerns over GM crops contaminating their non-GM kin have led to a stalemate in progress towards acceptance of GM crops and foods. We look at a new approach using gene silencing and gene imprinting.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
Subscribe now!
 
Jobs